Large-molecule drugs such as insulin and other proteins require delivery via injection or intravenous infusion. That typically limits their routine use to the most dire circumstances, given the associated inconvenience, expense and pain. To address that, drug delivery guru Robert Langer and other MIT researchers have teamed up with Novo Nordisk A/S to enable the delivery of injectable drugs via an ingestible pill that delivers a shot into the lining of the stomach.